We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$275M
Cap. Flow
+$223M
Cap. Flow %
22.14%
Top 10 Hldgs %
24.16%
Holding
3,706
New
246
Increased
2,543
Reduced
445
Closed
132

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.6M
2
NVDA icon
NVIDIA
NVDA
+$8.23M
3
MSFT icon
Microsoft
MSFT
+$7.53M
4
AMZN icon
Amazon
AMZN
+$3.51M
5
META icon
Meta Platforms (Facebook)
META
+$3.34M

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Financials 11.78%
3 Healthcare 9.71%
4 Industrials 7.92%
5 Consumer Discretionary 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOX icon
2776
Vanguard Communication Services ETF
VOX
$5.85B
$1.75K ﹤0.01%
+12
New +$1.66K
CLDX icon
2777
Celldex Therapeutics
CLDX
$3.28B
$1.73K ﹤0.01%
51
+41
+410% +$1.56K
SNDX icon
2778
Syndax Pharmaceuticals
SNDX
$1.82B
$1.71K ﹤0.01%
89
-1
-1% -$21
ELVN icon
2779
Enliven Therapeutics
ELVN
$4.43B
$1.69K ﹤0.01%
66
+17
+35% +$394
BRSL
2780
Brightstar Lottery PLC
BRSL
$2.03B
$1.68K ﹤0.01%
79
+46
+139% +$988
CTOS icon
2781
Custom Truck One Source
CTOS
$2.37B
$1.67K ﹤0.01%
+484
New +$2.04K
PFS icon
2782
Provident Financial Services
PFS
$3.19B
$1.67K ﹤0.01%
+90
New +$1.59K
SFST icon
2783
Southern First Bancshares
SFST
$600M
$1.67K ﹤0.01%
49
+5
+11% +$161
MNDY icon
2784
monday.com
MNDY
$3.94B
$1.67K ﹤0.01%
+6
New +$1.49K
CRML icon
2785
Critical Metals Corp
CRML
$1.06B
$1.65K ﹤0.01%
+222
New +$1.99K
RXRX icon
2786
Recursion Pharmaceuticals
RXRX
$1.73B
$1.65K ﹤0.01%
250
-6,166
-96% -$44.2K
PWP icon
2787
Perella Weinberg Partners
PWP
$1.3B
$1.64K ﹤0.01%
85
+72
+554% +$1.32K
MLP icon
2788
Maui Land & Pineapple Co
MLP
$344M
$1.64K ﹤0.01%
73
THRD
2789
DELISTED
Third Harmonic Bio
THRD
$1.63K ﹤0.01%
120
+7
+6% +$87
ROOT icon
2790
Root
ROOT
$798M
$1.63K ﹤0.01%
43
NCMI icon
2791
National CineMedia
NCMI
$378M
$1.61K ﹤0.01%
+229
New +$1.4K
FMB icon
2792
First Trust Managed Municipal ETF
FMB
$2.06B
$1.61K ﹤0.01%
31
NN icon
2793
NextNav
NN
$2.23B
$1.61K ﹤0.01%
215
+67
+45% +$517
TBPH icon
2794
Theravance Biopharma
TBPH
$877M
$1.6K ﹤0.01%
198
-86
-30% -$745
OPY icon
2795
Oppenheimer Holdings
OPY
$1.2B
$1.59K ﹤0.01%
+31
New +$1.58K
BKE icon
2796
Buckle
BKE
$2.37B
$1.58K ﹤0.01%
36
+16
+80% +$657
TD icon
2797
Toronto Dominion Bank
TD
$200B
$1.58K ﹤0.01%
25
MODV
2798
DELISTED
ModivCare
MODV
$1.57K ﹤0.01%
110
+30
+38% +$688
SPRY icon
2799
ARS Pharmaceuticals
SPRY
$612M
$1.55K ﹤0.01%
107
+31
+41% +$369
TV icon
2800
Televisa
TV
$1.49B
$1.55K ﹤0.01%
604
-2,060
-77% -$4.51K

Similar funds

GAMMA Investing's Q3 2024 Portfolio in Review

As of Q3 2024, GAMMA Investing held 3,706 positions worth $1.01B, up 37% from $734M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

GAMMA Investing deployed $223M of net new capital in Q3 2024, opening 246 new positions and adding to 2,543 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 28,428 shares worth $2.61M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Chevron, an estimated $216K trimmed.

  • GAMMA Investing's largest Q3 2024 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 28,428 shares worth $2.61M.
  • GAMMA Investing added most to Apple in Q3 2024, an estimated $11.6M increase.
  • GAMMA Investing's biggest Q3 2024 reduction was Chevron, cutting an estimated $216K.
  • GAMMA Investing fully exited iShares iBonds 2025 Term High Yield and Income ETF in Q3 2024, selling an estimated $1.21M.
  • GAMMA Investing's ten largest holdings make up 24% of its $1.01B portfolio in Q3 2024.
  • GAMMA Investing opened 246 new positions and closed 132 in Q3 2024.
  • GAMMA Investing's portfolio value rose 37% quarter-over-quarter to $1.01B.

Based on GAMMA Investing's 13F filing for Q3 2024, filed 7 Oct 2024.